Post-earnings recap
Reported
Tue, Oct 11, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
0%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CytoDyn Inc. reported a loss per share of $0.03, with no revenue reported. Despite these results, the stock rose by 1.23%, indicating that investors may have had lower expectations or are reacting positively to other factors not detailed in the earnings report.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.03 | N/A | — |
| Revenue | $0 | N/A | — |
No transcript is on record, and the analysis is based solely on numerical results.